MCRB
Seres Therapeutics
$4.85
−$0.12 (−2.32%)Jul 27, 2026
Key metrics
The numbers that frame MCRB today
- Market cap
- $46.97M
- P/E (TTM)
- -1.0
- EV / FCF
- -2.1
- Gross margin
- 100%
- EV / Sales
- 77.6
- ROIC
- -32.1%
- Div yield
- 0%
- Debt / equity
- 3.0
- 52wk Low
- $4.85
- 52wk High
- $29.98
Growth
Revenue and earnings trend for MCRB
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about MCRB
Is Seres Therapeutics a good buy?
No. Seres Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case. We think Seres Therapeutics is selling at a very high price.
What is the market capitalization of MCRB?
Seres Therapeutics's market capitalization is $46.97M.
What is the P/E ratio for MCRB stock?
Seres Therapeutics's current P/E ratio is -1.
What is the 52-week high for MCRB stock?
The 52-week high for Seres Therapeutics is $29.98. The current close of $4.85 is 83.8% below that high.
What is the 52-week low for MCRB stock?
The 52-week low for Seres Therapeutics is $4.85. The current close of $4.85 is 0% above that low.
Does MCRB stock pay dividends?
Seres Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for MCRB?
Seres Therapeutics's Debt / Equity ratio is 3.04.